M. Konstam's Profile

Role	Title	Level	Year	L/R
🐜	Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. 12 auth. R. Bresalier, R. Sandler, H. Quan, J. Bolognese, B. Oxenius, K. Horgan, ... C. Lines, R. Riddell, D. Morton, Á. Lanas, M. Konstam, J. Baron	11	2005	11 🐜
🐜	Forecasting the Impact of Heart Failure in the United States: A Policy Statement From the American Heart Association 14 auth. P. Heidenreich, N. Albert, L. Allen, D. Bluemke, J. Butler, G. Fonarow, J. Ikonomidis, Olga A. Khavjou, M. Konstam, T. Maddox, ... G. Nichol, Michael X. Pham, I. Piña, J. Trogdon	11	2013	11 🐜
🦁	Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. 12 auth. M. Konstam, M. Gheorghiade, J. Burnett, L. Grinfeld, A. Maggioni, K. Swedberg, ... J. Udelson, F. Zannad, T. Cook, J. Ouyang, C. Zimmer, C. Orlandi	10	2007	10 🦁
🐜	HFSA 2006 comprehensive heart failure practice guideline 25 auth. K. Adams, J. Lindenfeld, J. Arnold, D. Baker, D. Barnard, K. Baughman, J. Boehmer, P. Deedwania, S. Dunbar, U. Elkayam, M. Gheorghiade, J. Howlett, M. Konstam, M. Kronenberg, B. Massie, ... M. Mehra, Alan Miller, D. Moser, J. Patterson, R. Rodeheffer, J. Sackner-Bernstein, M. Silver, R. Starling, L. Stevenson, L. Wagoner	9	2006	9 🐜
🐜	Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. 12 auth. M. Gheorghiade, M. Konstam, J. Burnett, L. Grinfeld, A. Maggioni, K. Swedberg, ... J. Udelson, F. Zannad, T. Cook, J. Ouyang, C. Zimmer, C. Orlandi	9	2007	9 🐜
🐜	Acute Heart Failure Syndromes: Current State and Framework for Future Research 12 auth. M. Gheorghiade, F. Zannad, G. Sopko, L. Klein, I. Piña, M. Konstam, ... B. Massie, E. Roland, S. Targum, S. Collins, G. Filippatos, L. Tavazzi	9	2005	9 🐜
🐜	Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. 7 auth. A. Al-Ahmad, W. Rand, G. Manjunath, M. Konstam, D. Salem, A. Levey, ... M. Sarnak	9	2001	9 🐜
🦁	Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. M. Konstam, Daniel G. Kramer, Ayan R. Patel, M. Maron, J. Udelson	9	2011	9 🦁
🐜	Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE) 7 auth. M. Packer, R. Califf, M. Konstam, H. Krum, J. McMurray, J. Rouleau, ... K. Swedberg	9	2002	9 🐜
🦁	Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril on the Long‐term: Progression of Left Ventricular Dysfunction in Patients With Heart Failure 16 auth. M. Konstam, M. Rousseau, M. Kronenberg, J. Udelson, J. Melin, D. Stewart, N. Dolan, T. Edens, Sylvie A. Ahn, D. Kinan, ... D. Howe, L. Kilcoyne, J. Metherall, C. Benedict, S. Yusuf, H. Pouleur	9	1992	9 🦁
🦁	Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial 11 auth. M. Konstam, J. Neaton, K. Dickstein, H. Drexler, M. Komajda, F. Martinez, ... G. Riegger, W. Malbecq, Ronald D. Smith, S. Guptha, P. Poole‐Wilson	9	2009	9 🦁
🦁	Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association 12 auth. M. Konstam, M. Kiernan, D. Bernstein, B. Bozkurt, M. Jacob, N. Kapur, ... R. Kociol, E. Lewis, M. Mehra, F. Pagani, A. Raval, C. Ward	8	2018	8 🦁
🐜	Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials. 15 auth. P. Shekelle, M. Rich, S. Morton, Col Sid W Atkinson, W. Tu, M. Maglione, S. Rhodes, M. Barrett, G. Fonarow, B. Greenberg, ... P. Heidenreich, Tom Knabel, M. Konstam, A. Steimle, Lynne Warner Stevenson	8	2003	8 🐜